Statin Use and Microbleeds in Patients With Spontaneous Intracerebral Hemorrhage

Abstract

Statin use in patients with ICH is independently associated with MB, especially csMB. Future studies are needed to confirm our findings and to investigate whether csMB can serve as a surrogate marker for ICH risk in statin-treated patients.